Integrin α2 (CD49b) blockade remodels the tumor immune microenvironment and enhances anti-PD-L1 therapy in 4T1 breast cancer model

I. Eissa Yong-Tao Wang Kenneth K. Tanabe

Sep 2026 · Breast Cancer Research and Treatment · Vol 219 · 0 citations · 38 references

Medicine

View source